Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Second Experience

American Journal of Hematology - United States
doi 10.1002/ajh.25063
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Single Patient Experience

American Journal of Hematology
Hematology
2017English

Hemophagocytic Lymphohistiocytosis

2020English

Use of Extracorporeal Support in Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichiosis

Pediatrics
Child HealthPediatricsPerinatology
2016English

Hemophagocytic Lymphohistiocytosis in a Young Child

International Journal Of Medical Science And Clinical Invention
2017English

Hemophagocytic Lymphohistiocytosis in an AIDS Patient With Kaposi Sarcoma: A Treatment Dilemma

Case Reports in Hematology
2019English

Recent Advances in the Diagnosis and Treatment of Hemophagocytic Lymphohistiocytosis

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

Lytic Viral Replication and Immunopathology in a Cytomegalovirus-Induced Mouse Model of Secondary Hemophagocytic Lymphohistiocytosis

Virology Journal
VirologyInfectious Diseases
2017English

Pulmonary Lymphomatoid Granulomatosis With Hemophagocytic Lymphohistiocytosis as the Initial Manifestation

Frontiers in Oncology
Cancer ResearchOncology
2020English

Post-Transfusion Hemophagocytosis Without Hemophagocytic Lymphohistiocytosis

Mayo Clinic Proceedings: Innovations, Quality & Outcomes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy